13 October 2015, Iselin, NJ – Ansell Healthcare Products LLC, a wholly owned subsidiary of Ansell Ltd., a global leader in protection solutions, today announced that on October 13, 2015, Ansell has filed a patent infringement lawsuit against Reckitt Benckiser LLC for their distribution of the "Durex RealFeel®" condom. The action, filed in the United States District Court for the District of Delaware, alleges that the RealFeel condom infringes United States Patent Nos. 8,087,412; 8,464,719; 9,074,027; and 9,074,029, all of which are entitled "Dip-formed Synthetic Polyisoprene Latex Articles with Improved Intraparticle and Interparticle Crosslinks."
In November 2014, as part of a global strategy to protect its valuable intellectual property protecting Ansell’s non-latex SKYN® condom product line, Ansell filed a patent infringement suit against Reckitt Benckiser (Australia) Pty Limited in the New South Wales District Registry of the Federal Court of Australia regarding the Australian counterpart patent (Australian Patent No. 2009241426) to the U.S. Patents. The Australian litigation is presently entering the discovery phase.
Ansell is requesting a permanent injunction to stop Reckitt Benckiser from engaging in any of the following activities in the United States during the term of the Patents, without the license or authority of Ansell:
- Importing the Durex RealFeel product into the United States;
- Selling, supplying or otherwise disposing of the Durex RealFeel product in the United States; and
- Offering to sell, supply or otherwise dispose of the Durex RealFeel product in the United States.
In addition, Ansell is seeking:
- Damages, including enhanced damages pursuant to 35 U.S.C. § 284, attorney fees pursuant to 35 U.S.C. § 285, and further costs, interest or other relief as the Court deems just and proper.
Ansell is represented by Morgan, Lewis & Bockius LLP.